Impact of oxytocin discontinuation on fetal heart rate and uterine contractility: A pre-specified ancillary analysis embedded within a randomized trial

What Was Tested

The paper reports a study of Oxytocin, published as a randomized controlled trial.

The researchers aimed to assess the impact of oxytocin discontinuation at the onset of the active phase of labor on FHR patterns and uterine contractility.

Why It Was Studied

Oxytocin is widely used to augment uterine contractions during labor.

Who Took Part

PubMed indexes the participants as adults, women only.

Participants who received oxytocin before 4 cm dilation were randomly assigned (1:1) to either oxytocin discontinuation or oxytocin continuation.

For the present analysis, the researchers included women from the per-protocol discontinuation group of the parent trial.

How the Study Was Run

In design terms this was a randomized, open-label and multicenter study.

Because people in this Oxytocin study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Everyone knew when Oxytocin was being given (open label), which is simpler to run but leaves more room for expectations to affect what is reported.

Running at several centres spread the Oxytocin study over different clinics and patient groups.

Inclusion was restricted to the six centers with electronic cardiotocography storage where valid cardiotocography recordings were available for at least 1 h before and 1 h after oxytocin discontinuation.

Using a paired before-and-after design, FHR parameters (classified according to FIGO criteria) and uterine activity were compared during the 60 min preceding versus the 60 min following oxytocin discontinuation by independent obstetricians blinded to neonatal outcomes.

What Was Measured

The subject headings attached to it are Oxytocin, Heart Rate, Fetal, Uterine Contraction, Oxytocics, Cardiotocography, France and Labor, Obstetric.

Author keywords: fetal heart rate, hypoxia and uterine contractility.

What This Means in Plain Language

The paper is a randomized, open-label and multicenter study of Oxytocin.

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2026 (Acta obstetricia et gynecologica Scandinavica), a journal based in United States.

More context: the Oxytocin compound page, all human trials.